{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:18:43Z","timestamp":1776835123413,"version":"3.51.2"},"reference-count":24,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"unspecified","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2020,1,19]]},"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Therapeutic plasma exchange (TPE) for semi-critical neurological manifestations can be managed in non-acute setting instead of critical care unit. In 2014, we established a non-acute neurology TPE unit for semi-critical haemodynamically stable patients. In this study, we aimed to evaluate the technical and safety parameters from the first 3 years of service.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and methods<\/jats:title>\n                  <jats:p>We analysed prospectively collected TPE data for patients treated with centrifugation TPE at our non-acute neurology TPE unit in Kuala Lumpur Hospital between May 2015 and June 2018.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 245 TPE procedures were performed in 55 patients for nine neurological indications, predominantly the central nervous system (79%). Twenty four per cent (n=13) had category I and 73% (n=40) had category II indication (American Society for Apheresis (ASFA) 2019). Others (4%) were not in ASFA indications. Neuromyelitis optica spectrum disorders accounted for half (51%) of the total patients. Twenty-three (41.8%) patients experienced adverse events, with hypotensive episodes being the the most common (n=12\/55, 21.8%). Five (9.1%) patients had catheter-related blood stream infection, correlating with higher exchange plasma volume (p=0.023). Symptomatic hypocalcaemia was less common (n=5\/55, 9.1%) and allergic reaction to human albumin was rare (n=1\/55, 1.8%). Four technical errors detected. Three involved centrifugation sets manufacturing defects and one involved error in centrifugation set installation. Seven (2.9%) procedures were terminated: 5 for adverse effects and 2 for technical errors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Performing TPE among semi-critical patients with neurology manifestations in basic non-acute set-up proved safe, with predictable complications. This set-up reduced the reliance on critical care services for TPE procedures.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjno-2019-000020","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T13:31:50Z","timestamp":1592227910000},"page":"e000020","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Therapeutic plasma exchange (TPE) for semi-critical neurology presentations in a non-acute neurology set-up: clinical practice and challenges"],"prefix":"10.1136","volume":"2","author":[{"given":"Keng Seng","family":"Fu","sequence":"first","affiliation":[{"name":"Department of Neurology, Hospital Kuala Lumpur, Kuala Lumpur, Wilayah Persekutuan, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei Yin","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Kuala Lumpur, Kuala Lumpur, Wilayah Persekutuan, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4708-3734","authenticated-orcid":false,"given":"Fu Liong","family":"Hiew","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hospital Kuala Lumpur, Kuala Lumpur, Wilayah Persekutuan, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"key":"2025072811412583000_2.1.e000020.1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12629"},{"key":"2025072811412583000_2.1.e000020.2","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21257"},{"key":"2025072811412583000_2.1.e000020.3","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2012.1.7"},{"key":"2025072811412583000_2.1.e000020.4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"2025072811412583000_2.1.e000020.5","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-52001-2.00025-X"},{"key":"2025072811412583000_2.1.e000020.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00339-1"},{"key":"2025072811412583000_2.1.e000020.7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ncl.2018.01.002","article-title":"Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology","volume":"36","author":"Hehir","year":"2018","journal-title":"Neurol Clin"},{"key":"2025072811412583000_2.1.e000020.8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/jca.21529","article-title":"Plasma exchange in the intensive care unit: technical aspects and complications","volume":"32","author":"Lemaire","year":"2017","journal-title":"J Clin Apher"},{"key":"2025072811412583000_2.1.e000020.9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jca.21696","article-title":"The establishment of in-house neurology driven therapeutic plasma exchange infrastructure in a resource-limited public hospital in Malaysia: adopting and integrating evidenced-based health care technology through time","volume":"34","author":"Viswanathan","year":"2019","journal-title":"J Clin Apher"},{"key":"2025072811412583000_2.1.e000020.10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jca.20303","article-title":"Therapeutic apheresis: a review of complications and recommendations for prevention and management","volume":"26","author":"Mokrzycki","year":"2011","journal-title":"J Clin Apher"},{"key":"2025072811412583000_2.1.e000020.11","unstructured":"Hakim RM , Siami GA . Plasmapheresis. In: Daugirdas JT , Ing TS , eds. Handbook of dialysis. 2nd edn. Boston: Little, Brown and Company, 1994: 220."},{"key":"2025072811412583000_2.1.e000020.12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-0502(03)00121-6","article-title":"Therapeutic apheresis in Sweden: update of epidemiology and adverse events","volume":"29","author":"Norda","year":"2003","journal-title":"Transfus Apher Sci"},{"key":"2025072811412583000_2.1.e000020.13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12288-016-0661-3","article-title":"Therapeutic plasma exchange in patients with neurologic disorders: review of 63 cases","volume":"33","author":"Tombak","year":"2017","journal-title":"Indian J Hematol Blood Transfus"},{"key":"2025072811412583000_2.1.e000020.14","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/jca.21623","article-title":"Therapeutic plasma exchange: experience in a third level Hospital, 2013-2016, lima (Peru)","volume":"33","author":"Palma-Garcia","year":"2018","journal-title":"J Clin Apher"},{"key":"2025072811412583000_2.1.e000020.15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jca.20038","article-title":"Apheresis in the Philippines","volume":"20","author":"Narciso","year":"2005","journal-title":"J Clin Apher"},{"key":"2025072811412583000_2.1.e000020.16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.clineuro.2017.05.006","article-title":"Guillain-Barr\u00e9 Syndrome, variants & forms fruste: Reclassification with new criteria","volume":"158","author":"Hiew","year":"2017","journal-title":"Clin Neurol Neurosurg"},{"key":"2025072811412583000_2.1.e000020.17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/jns.12282","article-title":"Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression","volume":"23","author":"Hung","year":"2018","journal-title":"J Peripher Nerv Syst"},{"key":"2025072811412583000_2.1.e000020.18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/cen3.12354","article-title":"Clinical characteristics of autoimmune optic neuritis","volume":"8","author":"Kawachi","year":"2017","journal-title":"Clinical and Experimental Neuroimmunology"},{"key":"2025072811412583000_2.1.e000020.19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.transci.2008.09.003","article-title":"World apheresis registry 2003\u20132007 data","volume":"39","author":"Stegmayr","year":"2008","journal-title":"Transfus Apher Sci"},{"key":"2025072811412583000_2.1.e000020.20","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.transci.2017.08.022","article-title":"Expanding nursing knowledge for therapeutic plasma exchange a literature review paper","volume":"56","author":"Main","year":"2017","journal-title":"Ransfus Apher Sci"},{"key":"2025072811412583000_2.1.e000020.21","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-017-0803-3","article-title":"Therapeutic plasma exchange in a tertiary care center: 185 patients undergoing 912 treatments - a one-year retrospective analysis","volume":"19","author":"Schmidt","year":"2018","journal-title":"BMC Nephrol"},{"key":"2025072811412583000_2.1.e000020.22","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1111\/trf.13850","article-title":"A randomized crossover study comparing membrane and centrifugal therapeutic plasma exchange procedures","volume":"56","author":"Kes","year":"2016","journal-title":"Transfusion"},{"key":"2025072811412583000_2.1.e000020.23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11255-015-1137-3","article-title":"Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective crossover study","volume":"48","author":"Hafer","year":"2016","journal-title":"Int Urol Nephrol"},{"key":"2025072811412583000_2.1.e000020.24","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/ndt\/gfx084","article-title":"Pro: high dose of therapeutic plasma exchange-mind the gap!","volume":"32","author":"Hafer","year":"2017","journal-title":"Nephrol Dial Transplant"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2019-000020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T18:41:36Z","timestamp":1753728096000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2019-000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,30]]},"published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1136\/bmjno-2019-000020"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2019-000020","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}